Earlier this week Celine Halioua (ODF2), founder and CEO of Loyal — a dog longevity biotech startup — announced something truly groundbreaking.
Loyal (ODF2) has earned what they believe to be the FDA’s first-ever formal acceptance that a drug can be developed and approved for lifespan extension.
As Celine says in her announcement; “I started Loyal 4 years ago with the explicit goal to get the first drug FDA approved for lifespan extension itself - no disease, just healthy, longer"..."We can't start selling the drug yet - we need to complete the safety and manufacturing technical sections - but this represents the lions share of the 'existential risk' of both the drug program, and of Loyal AKA - we are doing it!!!”
Laura Deming is a longevity biotech investor with an incredible batting average. 5 of 18 startups she’s backed so far have gone public. She was the first investor in Loyal and had this to say:
"This just dropped - the most important milestone in the history of longevity biotech. put simply, this is the FDA’s first-ever formal acceptance that a drug can be developed and approved to extend lifespan. the longevity field is evolving quickly. No one I know in the field would have said this was possible 5 years ago. Celine got it done in 4. It’s a massive win for both biotech founders and regulators, in establishing a pathway by which drugs (initially for dogs) can get approved for lifespan"
You’re about to listen to an archival interview with Celine just one and a half years into starting Loyal which is now 4 years old. It’s an incredible conversation with interviewer Marshall Kosloff and shows just how much can be accomplished in a few short years.
Congrats to Celine and the entire Loyal team on what is truly an unparalleled milestone.
Are you exploring starting a company we’ve got a program for that?
ODF has helped 1k companies like Loyal which was ODF2 get started and go on to raise over $2B. Applications for our 20th cohort in San Francisco are now . Learn more and apply at beondeck.com
The Pseudonymous Meritocracy with Bored Elon Musk
Training Emotional Fitness with Dr. Emily Anhalt
Decentralized Autonomous Organizations (DAOs) with Cooper Turley (AKA Coopahtroopa)
The Open-Source Renaissance with Peer Richelsen
Scaling Expertise with Dr. Hollis Robbins
The Next Crypto Cycle - web3, DAOs, and NFTs with Patrick Rivera
Reimagining Remote Work with Flo Crivello
Mission-Driven Cities with Marc Lore
Citizens of the Metaverse with Gaby Goldberg and Shriya Nevatia
Space 3.0 Delian Asparouhov, co-founder of Varda Space Industries and principal at Founders Fund
Creating New Categories: Metabolic Health with Sam Corcos & Andrew Conner, co-founders of Levels
On Ramps to Investing with Kyla Scanlon
Climate Technology with Candice Ammori
Internet Culture and Community with Fadeke Adegbuyi
How Packy McCormick Plays The Great Online Game
Thesis-Driven Investing with Rebecca Kaden, Managing Partner at Union Square Ventures
Ecommerce and the Vanishing Middle with Web Smith
Web3 with Jarrod Dicker, investor at the Chernin Group
The Future of Cities with Bradley Tusk, Political Strategist and Venture Capitalist at Tusk Ventures
Cracking Longevity with Celine Halioua, Founder and CEO of Loyal
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
Lex Fridman Podcast